Pneumonia News and Research

RSS
Pneumonia is a leading cause of death and hospitalization, costing health care systems billions of dollars and an estimated 600,000 adult deaths worldwide each year. Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae and the term describes a group of illnesses, including invasive infections, such as bacteremia/sepsis and meningitis, as well as pneumonia and upper respiratory tract infections. Although all age groups may be affected, the highest rate of pneumococcal disease occurs in young children and older adults. In addition, persons suffering from a wide range of chronic conditions (eg, diabetes, cardiovascular disease) and immune deficiencies are at increased risk.
Researchers Reveal Dual Nature of Beneficial Bacteria UD1022

Researchers Reveal Dual Nature of Beneficial Bacteria UD1022

Organoid Platform Could Help Reduce the Time for Developing New Conjugate Vaccines

Organoid Platform Could Help Reduce the Time for Developing New Conjugate Vaccines

Study reports a new target to fight against antibiotic-resistant pneumonia

Study reports a new target to fight against antibiotic-resistant pneumonia

Fomepizole may reduce disease severity in the lungs of mice with bacterial pneumonia

Fomepizole may reduce disease severity in the lungs of mice with bacterial pneumonia

Effective and faster methodology detects RNA viruses based on the triplex-forming probe technology

Effective and faster methodology detects RNA viruses based on the triplex-forming probe technology

New genetic condition that raises vulnerability to opportunistic infections

New genetic condition that raises vulnerability to opportunistic infections

Studying the association between gut microbe and Parkinson’s disease

Studying the association between gut microbe and Parkinson’s disease

Exploring behavioral variation in a non-captive animal population

Exploring behavioral variation in a non-captive animal population

Combating antibiotic-resistant bacteria with new drug

Combating antibiotic-resistant bacteria with new drug

Molecular responses of Pseudomonas aeruginosa to hydroquinine

Molecular responses of Pseudomonas aeruginosa to hydroquinine

Hydroquinine inhibits and kills several strains of clinically important bacteria

Hydroquinine inhibits and kills several strains of clinically important bacteria

Fabimycin likely to be an effective treatment for drug-resistant bacteria

Fabimycin likely to be an effective treatment for drug-resistant bacteria

Novel insights into how some bacteria evade antibiotics

Novel insights into how some bacteria evade antibiotics

Researchers detect major contamination in organic vegetables, likely to cause fatal illness

Researchers detect major contamination in organic vegetables, likely to cause fatal illness

Researchers discover a unique technique to fight hospital-borne disease

Researchers discover a unique technique to fight hospital-borne disease

Researchers use urinary proteomics to detect abnormalities inside the body

Researchers use urinary proteomics to detect abnormalities inside the body

Study shows how the immune system effectively combats coronavirus to prevent pneumonia

Study shows how the immune system effectively combats coronavirus to prevent pneumonia

New vaccine providing protection against future animal-to-human viral diseases may be possible

New vaccine providing protection against future animal-to-human viral diseases may be possible

Study identifies respiratory syncytial viral protein that mediates RSV-induced autophagy

Study identifies respiratory syncytial viral protein that mediates RSV-induced autophagy

Scientists discover “resistance gene” in harmful E. coli bacteria

Scientists discover “resistance gene” in harmful E. coli bacteria

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.